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Purpose: Previous studies have extensively investigated the 
pathophysiology, genetics, and lifestyle risk factors of  thyroid-
associated ophthalmopathy (TAO). The aim of this study was to 
investigate the independent contribution of ethnic origin, social 
grade, and level of social deprivation to TAO severity in a large, 
multiethnic, and urban population.
Methods: Retrospective case note review of all TAO patients 
seen at Birmingham and Midland Eye Centre, United Kingdom 
over a 14-year period. Ethnicity (White, Asian, or Black) was 
recorded, and residence postcode was used to determine social 
grade (National Readership Survey classification) and level of 
social deprivation (Index of Multiple Deprivation 2007). TAO 
severity was defined by European Group on Graves’ Orbitopathy 
criteria. Moderate-to-severe: necessity for TAO treatment with 
oral or intravenous steroid, long-term immunosuppressants, 
or orbital radiotherapy. Sight-threatening: presence of 
dysthyroid optic neuropathy (DON) or need for urgent orbital 
decompression surgery. Multivariable logistic regression was 
performed to measure the independent influence of ethnicity, 
social grade, and social deprivation on indicators of severe TAO.
Results: Lower social grade was significantly associated with 
increased odds ratio (OR) of TAO patients having severe TAO, 
including treatment with oral (OR: 2.3 (95% CI 1.1–5.1) p = 0.03) 
and intravenous steroid (OR: 2.6 (95% CI 1.0–7.0) p = 0.04) and 
DON (OR: 4.0 (95% CI 1.2–12.7) p = 0.02), compared with those 
of highest social grade. Similar results were observed for social 
deprivation. Ethnicity had no independent association with any 
measure of TAO severity.
Conclusions: In this cohort, lower social grade and 
higher social deprivation, but not ethnicity, had independent, 
statistically significant association with more severe TAO.
(Ophthal Plast Reconstr Surg 2014;30:241–245)
Thyroid-associated ophthalmopathy (TAO), also known as thy-roid eye disease or Graves’ Orbitopathy, is an inflammatory 
orbital condition of multifactorial aetiology which, although often 
mild and self-limiting, may be sight-threatening in 3% to 5%.1,2
The European Group on Graves’ Orbitopathy (EUGOGO) 
recommends classification of TAO severity in 3 categories 
(Table 1). Numerous studies have extensively investigated the 
pathogenesis, genetic susceptibility, lifestyle risk factors, and 
psychosocial effects of TAO. However, as yet, there appears to 
have been little consideration of ethnicity, socioeconomic posi-
tion, or level of social deprivation as influences on the presenta-
tion, activity or severity of TAO, nor on the eventual quantifiable 
burden of medical and surgical intervention.
Ethnicity and social grade have previously been shown to 
be determinants of disease prevalence and severity in a range of 
inflammatory and noninflammatory systemic conditions (e.g., 
hypertension, cardiovascular and renal disease, diabetes mel-
litus, inflammatory bowel disease, systemic lupus erythema-
tosus, rheumatoid arthritis)3–8 and also ophthalmic conditions 
(e.g., primary open angle and primary angle closure glaucoma, 
keratoconus, cataract, retinopathy of prematurity, refractive 
errors),9–13 but such literature in TAO is limited.
Tellez at al.14 (1992) were the first to consider the influence 
of ethnicity on TAO, comparing ophthalmic signs in European and 
Asian (predominantly from the Indian subcontinent) patients with 
newly diagnosed Graves’ disease (GD) presenting to an endocrinol-
ogy clinic. This study found that the prevalence of TAO and overall 
risk of TAO development in Europeans were 6.4 times higher than 
that of Asian patients. However, Lim et al.15 (2008) found similar 
prevalence of TAO in Asian (Malay, Chinese, and Indian) patients 
with GD as compared with Caucasian GD patients.
It has been proposed that anatomical variations (e.g., orbital 
dimensions such as depth and apex width, eyelid configuration, and 
normal upper limit of proptosis measurements) and differences in 
the frequency of genetic polymorphisms (e.g., human leukocyte 
antigen [HLA] susceptibility loci, cytotoxic T-lymphocyte anti-
gen-4 [CTLA-4] genes) underpin the apparent diversity in TAO 
clinical features between different ethnicities.16 However, extensive 
searches of medical literature databases revealed no data regarding 
Afro-Caribbean ethnicity and TAO nor data examining the rela-
tionship between socioeconomic status and TAO. The aim of this 
study was therefore to investigate the relationship between ethnic-
ity, social grade, and level of social deprivation with TAO severity.
METHODS
Retrospective case note review of all patients seen for TAO at 
Birmingham and Midland Eye Centre (BMEC), United Kingdom, between DOI: 10.1097/IOP.0000000000000077
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January 1998 and March 2012. A diagnosis of TAO was made according 
to clinical examination (presence of upper or lower eyelid retraction, ex-
ophthalmos, inflammatory signs of the ocular and periocular tissues, and 
restrictive myopathy), deranged thyroid function tests (TFTs), presence of 
thyroid autoantibodies, and radiologic signs (enlargement of extraocular 
muscles or orbital fat). Institutional review board was waived for this study.
A minimum period of follow up of 2 years (or definitive dis-
charge from ophthalmic care) was stipulated to capture the full 
period of TAO inflammatory activity and consequent medical and sur-
gical interventions. Note was taken of documented ethnicity—White 
 (White-British, White-Irish, and White-Other), Asian (Indian, Pakistani, 
and Bangladeshi), or Black (African or Caribbean). Residence post-
code was used to determine National Readership Survey (NRS) social 
grade and the level of social deprivation according to Index of Multiple 
Deprivation 2007 (IMD 2007).
The NRS classification is a demographic system of social grade 
classification based on the occupation of the chief income earner of the 
household and has been used since the 1960s (Table 2).17 IMD 2007 is a 
well-validated indicator of social deprivation that integrates 7 “domains” 
of deprivation (income, employment, health deprivation and disability, 
educational skills and training, barriers to housing and services, crime, and 
living environment) that are combined, with appropriate weighting, in a 
single, overall deprivation score and ranking for each geographical area.9
For all analyses related to social grade, the 6 NRS classifica-
tions were abbreviated to 3 (A&B, C1&C2, and D&E). For all analy-
ses related to social deprivation, TAO patients were ranked from lowest 
(least deprived) to highest (most deprived) score and divided into West 
Midlands-specific IMD 2007 quintiles, with quintile 1 the least deprived 
and quintile 5 the most deprived.
The measures chosen to define EUGOGO “moderate-to-severe” 
TAO were need for treatment with oral (prednisolone) or intravenous 
steroid (methylprednisolone), need for long-term immunosuppressant 
treatment (e.g., azathioprine, methotrexate, or ciclosporin), and need 
for orbital radiotherapy. The markers chosen to determine EUGOGO 
“sight-threatening” TAO were the presence of DON (clinically or on 
electrodiagnostic testing) and the need for urgent orbital decompres-
sion surgery for DON. In addition, the authors analyzed for influence 
on whether patients had evidence of active TAO (defined as a Clinical 
Activity Score [CAS] of ≥3) at the time of original presentation.
One-way analysis of variance (ANOVA) (with Bonferroni post hoc 
test) was used to compare age, Fisher exact test was used to compare pro-
portions of all other demographic factors, and TAO severity markers in each 
ethnic group, social grade, and IMD 2007 quintile. Chi-square test com-
pared the frequency of TAO patients observed in each West Midlands IMD 
2007 quintile with the frequency expected. Multivariable logistic regression 
was then performed to simultaneously measure the influence (in the form of 
odds ratios [OR]) of a number of independent variables–age, gender, ciga-
rette smoking status, NRS social grade, IMD 2007 deprivation quintile, and 
ethnicity—on markers of TAO severity as determined by the EUGOGO 
severity classification. Data were analyzed by using SPSS version 18 (IBM, 
Chicago, IL). p ≤ 0.05 was considered statistically significant.
RESULTS
Three hundred and forty-three TAO patients were seen during the 
study period. Complete medical records of at least 2 years follow up were 
available for 273 (80%) of these. Mean age (SD) was 49 ± 14 years (range 
17–87 years), with 74% (201/273) women, 72% (196/273) aged >40 
years at time of presentation, and 36% (99/273) smokers. Of all TAO sub-
jects, 77% (210/273) were of White ethnic origin, 12% (32/273) Asian, 
and 11% (31/273) Black. Two patients, each of White ethnic origin, had 
postcodes for which it was not possible to gain an IMD 2007 score and 
were therefore not included in these analyses. No patients were of East 
Asian (Chinese, Japanese, Korean, and Taiwanese) ethnic origin.
White subjects were significantly older than Asian and Black 
TAO subjects (mean age 51 years vs 42 and 43 years; p < 0.0001 and 
p < 0.001, respectively). White patients were more likely to be in social 
grade A&B than Asian or Black individuals (27% vs 16% and 10%, re-
spectively; p = 0.04) and were also more likely to be in the least deprived 
quintile 1 (17% vs 3% and 0%, respectively; p = 0.04) and less likely 
to be in the most deprived quintile (22% vs 44% and 55%, respectively, 
p = 0.01). Furthermore, White subjects were more likely to smoke (40% 
vs 31% and 16%, respectively; p = 0.01) and be women (78% vs 56% 
and 61%, respectively; p = 0.01).
Chi-square comparison of the TAO patient frequency in each of 
the West Midlands IMD 2007 quintiles with the expected frequency of 
one-fifth in each quintile determined that there was statistically significant 
overrepresentation of TAO patients with higher levels of deprivation than 
that predicted from the reference population (p < 0.0001) (Table 3).
TABLE 2. national readership Survey social grade 
classification with percentage of the United Kingdom 
population (2010) represented in each grade.17
Social 
grade Description % Population
A Higher managerial, administrative, and 
professional
4
B Intermediate managerial, administrative, and 
professional
22
C1 Supervisory, clerical and junior managerial, 
administrative, and professional
29
C2 Skilled manual workers 21
D Semi-skilled and unskilled manual workers 15
E State pensioners, casual and lowest grade 
workers, unemployed with state benefits only
8
TABLE 3. Frequency of index of Multiple Deprivation 
2007 values by quintile in patients with thyroid-
associated ophthalmopathy as compared with expected 
frequency in the population
Deprivation, quintile
West Midlands 
IMD 2007 score
TAO patients, in 
quintile
Expected 
frequency
1 (Least deprived) 1.33–10.07 37 (14%) 54.2
2 10.08–16.34 36 (13%) 54.2
3 16.35–25.07 47 (17%) 54.2
4 25.08–40.62 74 (27%) 54.2
5 (Most deprived) 40.63–80.34 77 (28%) 54.2
Total 271 271
Χ2 = 29.4; df = 4; p < 0.0001.
IMD, index of multiple deprivation; TAO, thyroid-associated ophthalmopathy.
TABLE 1 Severity of TAO as defined by the European 
Group on Graves’ Orbitopathy (EUGOGO).2
EUGOGO severity Description
Mild Patients with TAO that does not have a major 
impact on their life and therefore does not 
require medical or surgical treatment
Moderate-to-severe Patients without sight-threatening TAO, but 
with disease that affects their everyday 
existence to an extent sufficient to warrant 
immunosuppressive treatment (if features 
of active TAO are manifest) or surgical 
rehabilitation (if there are no features of 
active TAO)
Sight-threatening Patients who require urgent medical or 
surgical intervention for dysthyroid optic 
neuropathy (DON) or corneal compromise 
(with, e.g., intravenous glucocorticoid or 
urgent orbital decompression surgery)
© 2014 The American Society of Ophthalmic Plastic and Reconstructive Surgery, Inc. 243
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Overall, the rate for the need for treatment with oral steroid was 
33% (89/273), intravenous steroid 19% (53/273), immunosuppressants 
8% (21/273), and orbital radiotherapy 7% (19/273). Rates of DON were 
16% (43/273) and orbital decompression 9% (25/273). Univariable 
comparison of the frequency of these measures of TAO severity between 
different ethnicities, NRS social grades, and IMD 2007 social depri-
vation scores revealed increased proportions of patients requiring oral 
(p = 0.02) and intravenous steroid (p = 0.03), having DON (p = 0.01) 
and requiring orbital decompression (p = 0.04) in social grades D&E 
as compared with social grades A&B. Except for the requirement for 
orbital decompression, this was replicated in analyses related to IMD 
2007. However, there were no significant differences related to ethnicity.
Multivariable logistic regression demonstrated association be-
tween lower social grade (NRS D&E) and higher social deprivation 
scores (quintile 4) and increased odds of the presence of indicators of 
severe TAO, including need for treatment with oral and intravenous ste-
roid, and the presence of DON, compared with those of highest social 
grade (NRS A&B) and lowest social deprivation scores (quintile 1). 
However, once again ethnicity had no independent association with any 
measure of TAO severity (Tables 4 and 5).
DISCUSSION
This study demonstrates independent associations between 
lower social grade and higher social deprivation and statisti-
cally significant increased odds of features associated with 
more severe TAO, as compared with those of higher social 
grade and lower levels of social deprivation. No such associa-
tion was observed for ethnicity for any of the severity indices 
evaluated.
There are a number of possible explanations for such 
associations. Socioeconomic deprivation, as defined by not 
being in paid employment, has been found to be associated with 
nonattendance at hospital out-patient clinics.18 This could have 
been the case for crucial endocrine and ophthalmic follow-up 
appointments for those TAO subjects of lower social grade or 
higher levels of deprivation. These patients may also have pre-
sented later to medical care or had higher rates of nonadherence 
with treatment modalities. Dietary factors may also have been 
important. An “oxidative stress” model of TAO postulates that 
hypoxia related, for example, to smoking, results in production 
of free radicals, which stimulate orbital fibroblast proliferation, 
glycosaminoglycan production, and orbital tissue expansion. It 
may be the lower consumption of antioxidants (in fruit and veg-
etables) in those of lower social grade or higher social depriva-
tion that increases tendency to more severe TAO.19
We observed more definite independent associations 
of social position on TAO severity indices by using the NRS 
social grading rather than IMD 2007. IMD 2007 is a multi-
faceted measure of the level of social deprivation, encompass-
ing a wide range of different issues of social disadvantage, 
not only financial. It is therefore likely to be the more robust 
method of analysing the influence of lower social status on 
disease than NRS, which measures only the occupation of the 
chief income earner of the household. However, IMD 2007 
measures only deprivation within a postcode, not affluence. 
Not every person within a deprived area will necessarily be 
deprived. Likewise, there may be disadvantaged people liv-
ing in the least deprived areas. In addition, we could not take 
account of social mobility over the 14-year period of the study. 
The postcode at the time of original clinic attendance was 
used to define the social status of each individual. However, 
it is possible that a number of patients moved between social 
strata over the study period.
To minimize this possible confounding factor, we used 
IMD 2007 rather than the more up-to-date IMD 2010. IMD 
2007 is mostly based on data gained from 2004 to 2006, which 
were believed to be more equidistant between the start and end 
dates of data collection. Between IMD 2007 and IMD 2010, 63 
TAO patients’ postcode (23%) had a change in IMD score, with 
TABLE 4.  Multivariable logistic regression analysis for the influence (in the form of odds ratios) of independent 
variables on markers of severe thyroid-associated ophthalmopathy, including social grade.
Variable IV Steroid Oral steroid Radiotherapy Immunosuppression DON Decompression CAS≥3
Age
  ≤40 y 1.0 1.0 1.0 1.0 1.0 1.0 1.0
  >40 y 4.7 (1.8–12.4) 
p = 0.002
3.7 (1.8–7.6) 
 p < 0.0001
3.6 (0.8–17.4) 
p = 0.1
9.6 (1.2–77.7)  
p = 0.03
6.9 (2.0–24) 
p = 0.002
3.3 (0.9–12.0) 
p = 0.07
3.4 (1.5–7.5) 
p = 0.003
Gender
  Female 1.0 1.0 1.0 1.0 1.0 1.0 1.0
  Male 1.0 (0.5–2.0) 
p = 0.9
1.0 (0.5–1.8) 
p = 1.0
1.8 (0.7–4.9) 
p = 0.3
0.2 (0.05–1.0)  
p = 0.05
0.7 (0.3–1.5) 
p = 0.3
0.6 (0.2–1.7) 
p = 0.3
1.2 (0.6–2.3) 
p = 0.6
Smoking
  No 1.0 1.0 1.0 1.0 1.0 1.0 1.0
  Yes 1.4 (0.7–2.7) 
p = 0.3
1.6 (0.9–2.9) 
p = 0.09
2.0 (0.7–5.4) 
p = 0.2
2.7 (1.0–7.4)  
p = 0.05
1.3 (0.6–2.6) 
p = 0.5
0.8 (0.3–2.0) 
p = 0.6
2.0 (1.1–3.8) 
p = 0.02
Ethnicity
  White 1.0 1.0 1.0 1.0 1.0 1.0 1.0
  Asian 2.4 (0.9–6.5) 
p = 0.08
1.4 (0.6–3.3) 
p = 0.5
1.2 (0.2–6.5) 
p = 0.8
3.0 (0.7-13.0)  
p = 0.1
1.3 (0.4–4.4) 
p = 0.6
0.4 (0.05–3.7) 
p = 0.4
2.8 (1.1–7.0) 
p = 0.03
  Black 1.1 (0.4–3.2) 
p = 0.8
0.9 (0.4–2.2) 
p = 0.8
1.7 (0.4–7.0) 
p = 0.5
0.9 (0.1–7.8)  
p = 0.9
1.5 (0.5–4.4) 
p = 0.4
2.3 (0.7–7.3) 
p = 0.1
1.2 (0.4–3.2) 
p = 0.7
NRS social grade
  A & B 1.0 1.0 1.0 1.0 1.0 1.0 1.0
  C 1.7 (0.7–4.5) 
p = 0.3
2.1 (1.0–4.5) 
p = 0.05
2.2 (0.4–11.1) 
p = 0.3
2.5 (0.6–9.9) 
 p = 0.2
3.0 (1.0–9.7) 
p = 0.06
2.4 (0.5–12.4) 
p = 0.3
1.7 (0.7–3.8) 
p = 0.2
  D & E 2.6 (1.0–7.0) 
p = 0.04
2.3 (1.1–5.1) 
p = 0.03)
2.5 (0.5–12.7) 
p = 0.3
1.3 (0.3–5.7)  
p = 0.8
4.0 (1.2–12.7) 
p = 0.02
4.5 (0.9–21.6) 
p = 0.06
1.6 (0.7–3.7) 
p = 0.3
European Group on Graves’ Orbitopathy (EUGOGO) definitions of moderate-to-severe TAO are indicated in light gray and sight-threatening in dark gray.
CAS, Clinical Activity Score; DON, dysthyroid optic neuropathy; IV, intravenous; NRS, National Readership Survey.
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62 of these moving down a quintile in a more deprived group. 
Nevertheless, reanalysis of the data by using IMD 2010 demon-
strated similar results to those by using IMD 2007.
It was necessary to undertake the statistical method of 
multivariable logistic regression as the White population dif-
fered so significantly from the Asian and Black populations in 
important demographic factors such as age, gender, and smok-
ing status. The direct statistical comparison of the proportions 
of each social or ethnicity group having each indicator of severe 
TAO is subject to confounding due to these inherent differ-
ences. By undertaking multivariable logistic regression, we 
aimed to ‟pick apart” the different factors known to influence 
TAO development and gain an independent measure for each 
(Supplemental Digital Content, Tables 1 and 2, http://links.lww.
com/IOP/A77).
One of the most striking features of the data is that those 
aged greater than 40 years had increased odds of more severe 
TAO than those aged 40 years or less. Studies have already 
determined that there is an association between the severity of 
TAO and increased age and male gender.15,20 However, smok-
ing is the risk factor that has been most consistently associ-
ated with the development and severity of TAO, with those 
who stop smoking for at least a year having a risk equiva-
lent to never smokers.14,21 In other studies, more than 40% of 
smokers either developed or had worsening of TAO, almost 
double the rate of nonsmokers.21 It is therefore surprising that 
the authors’ study found few associations between smoking 
and severe TAO. There are a number of possible reasons for 
this. Although the statistical model incorporated a measure of 
whether each TAO patient smoked cigarettes at their original 
presentation, we did not classify patients by number of ciga-
rettes smoked per day. In addition, smoking status may have 
been underreported, and it was also not possible to determine 
whether the rate of smoking cessation following presentation 
with TAO, or the passive smoking rate, differed in those of 
different social status or ethnicity.
It may be argued that further independent risk factors for 
severe TAO should be incorporated in the multivariable logistic 
regression model. For example, the duration of underlying auto-
immune thyroid disease, thyroid autoantibody status, stability 
of TFTs, and previous treatment with radioactive iodine may 
also have had a significant contribution to the onset or worsen-
ing of TAO.22,23 These data were not available for incorporation 
in the analysis.
In conclusion, this is the first study to consider the 
independent influence of social grade, level of social depri-
vation, and ethnicity on TAO severity in a large cohort of 
patients from a diverse, multiethnic population. In this cohort, 
we have illustrated that increased age, lower social grade, and 
higher social deprivation, but not ethnicity, have statistically 
significant association with some markers of severe TAO. 
Future studies should investigate further the influence of 
social factors and ethnicity on aspects of TAO presentation, 
treatment burden, prognosis, and the complex mechanisms 
underpinning these.
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TABLE 5. Multivariable logistic regression analysis for the influence (in the form of odds ratios) of independent 
variables on markers of severe thyroid-associated ophthalmopathy, including social deprivation. 
Variable IV steroid Oral steroid Radiotherapy Immunosuppression DON Decompression CAS≥3
Age
  ≤40 y 1.0 1.0 1.0 1.0 1.0 1.0 1.0
  >40 y 4.3 (1.6–11.2) 
p = 0.003
3.4 (1.7–7.1) 
p = 0.001
3.6 (0.7–17.5) 
p = 0.1
9.0 (1.3–69.2)  
p = 0.04
6.6 (1.9–22.9) 
p = 0.003
3.7 (1.0–13.5) 
p = 0.05
3.1 (1.4–7.1) 
p = 0.007
Gender
  Female 1.0 1.0 1.0 1.0 1.0 1.0 1.0
  Male 1.0 (0.5–2.0) 
p = 0.9
1.0 (0.6–2.0) 
p = 0.9
2.0 (0.7–5.7) 
p = 0.2
0.2 (0.05–0.9)  
p = 0.04
0.7 (0.3–1.6) 
p = 0.4
0.6 (0.2–1.8) 
p = 0.4
1.3 (0.6–2.5) 
p = 0.5
Smoking
  No 1.0 1.0 1.0 1.0 1.0 1.0 1.0
  Yes 1.3 (0.7–2.6) 
p = 0.4
1.6 (0.9–2.7) 
p = 0.1
1.9 (0.7–5.2) 
p = 0.2
2.4 (1.1–6.5)  
p = 0.05
1.3 (0.6–2.6) 
p = 0.5
0.9 (0.3–2.2) 
p = 0.7
1.8 (1.0–3.4) 
p = 0.05
Ethnicity
  White 1.0 1.0 1.0 1.0 1.0 1.0 1.0
  Asian 1.9 (0.7–5.3) 
p = 0.2
1.1 (0.4–2.7) 
p = 0.9
1.2 (0.2–6.5) 
p = 0.8
2.7 (0.8–11.5)  
p = 0.2
1.0 (0.3–3.5) 
p = 1.0
0.4 (0.04–3.0) 
p = 0.4
2.3 (0.9–5.7) 
p = 0.09
  Black 1.1 (0.4–3.2) 
p = 0.9
0.9 (0.3–2.2) 
p = 0.7
1.3 (0.3–6.1) 
p = 0.7
0.9 (0.2–7.0) 
 p = 0.8
1.4 (0.5–4.3) 
p = 0.5
2.1 (0.6–7.0) 
p = 0.2
1.0 (0.4–2.7) 
p = 1.0
IMD 2007 Quintile
  1 (least deprived) 1.0 1.0 1.0 1.0 1.0 1.0 1.0
  2 2.8 (0.9–8.7) 
p = 0.07
2.8 (1.1–6.8) 
p = 0.03
2.5 (0.5–13.6) 
p = 0.3
1.6 (0.4–4.3)  
p = 0.2
1.6 (0.5–5.2) 
p = 0.5
0.6 (0.1–3.6) 
p = 0.5
4.2 (1.4–12.7) 
p = 0.01
  3 1.7 (0.5–5.8) 
p = 0.4
1.5 (0.6–3.8) 
p = 0.4
1.5 (0.2–9.8) 
p = 0.7
1.5 (0.7–3.9)  
p = 0.7
1.2 (0.3–4.5) 
p = 0.7
1.7 (0.4–7.8) 
p = 0.5
2.2 (0.7–7.2) 
p = 0.2
  4 3.3 (1.1–10.4) 
p = 0.04
3.5 (1.4–8.7) 
p = 0.008
1.2 (0.2–7.7) 
p = 0.9
2.5 (0.8–5.2) 
p = 0.7
3.1 (1.0–10) 
p = 0.05
2.4 (0.5–10.7) 
p = 0.2
3.2 (1.0–10.1) 
p = 0.04
  5 (most deprived) 2.4 (0.7–8.2) 
p = 0.1
2.4 (0.9–6.4) 
p = 0.07
2.4 (0.4–14.7) 
p = 0.3
1.8 (0.7–6.4) 
p = 0.4
2.2 (0.6–7.7) 
p = 0.2
3.1 (0.7–13.8) 
p = 0.1
3.5 (1.1–11.3) 
p = 0.03
CAS, Clinical Activity Score; DON, dysthyroid optic neuropathy; IMD, Index of Multiple Deprivation 2007; IV, intravenous.
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